Is there any priority between the alpha blockers on voiding functions after transrectal ultrasound guided prostate biopsy?

摘要

Transrectal ultrasound–guided prostate biopsy is the gold standard in the diagnosis of prostate cancer. Major and minor complications may develop at varying rates after prostate biopsies, one of which is voiding impairment. This study aimed to evaluate whether all alpha1-blockers were effective in preventing voiding impairment after a transrectal ultrasound–guided prostate biopsy and if so, was one superior to the others.